1-3 of 3
Ferdows Atiq
Close
Sort by
Journal Articles

VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion

Helen Fogarty, Azaz Ahmad, Ferdows Atiq, Dearbhla Doherty, Soracha Ward, Ellie Karampini, Aisling Rehill, Gemma Leon, Ciara Byrne, Rosena Geoghegan, Helena Conroy, Mary Byrne, Ulrich Budde, Sonja Schneppenheim, Ciara Sheehan, Noel Ngwenya, Ross I. Baker, Roger J. S. Preston, Emma Tuohy, Corrina McMahon, James S. O’Donnell
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6974–6989.
https://doi.org/10.1182/bloodadvances.2023010824
Published: 2023
Includes: Supplemental data
Journal Articles

Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease

Ferdows Atiq, Jessica Heijdra, Fleur Snijders, Johan Boender, Eva Kempers, Waander L. van Heerde, Dominique P. M. S. M. Maas, Sandy Krouwel, Selene C. Schoormans, Joke de Meris, Saskia E. M. Schols, Karin P. M. van Galen, Johanna G. van der Bom, Marjon H. Cnossen, Karina Meijer, Karin Fijnvandraat, Jeroen Eikenboom, Frank W. G. Leebeek
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5317–5326.
https://doi.org/10.1182/bloodadvances.2021006757
Published: 2022
Includes: Supplemental data
Journal Articles

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

Clinical Trials & Observations
Ferdows Atiq, Lisette M. Schütte, Agnes E. M. Looijen, Johan Boender, Marjon H. Cnossen, Jeroen Eikenboom, Moniek P. M. de Maat, Marieke J. H. A. Kruip, Frank W. G. Leebeek
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4147–4154.
https://doi.org/10.1182/bloodadvances.2019000863
Published: 2019